NCT05954377

Brief Summary

STROBERRY Study is a Prospective, monocentric, randomized, open-label study assessing the contribution of telemedicine, in addition to standard follow-up, strengthening an Obesity program in Berry (France). The principal objective is to study the effectiveness of a follow-up reinforced with telemedicine in addition to the standard multidisciplinary annual follow-up on the rate of patients lost to follow-up after initial or second line management in a multidisciplinary bariatric medical program

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
116

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
46mo left

Started Sep 2024

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Sep 2024Mar 2030

First Submitted

Initial submission to the registry

July 12, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 20, 2023

Completed
1.1 years until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2030

Last Updated

April 24, 2024

Status Verified

April 1, 2024

Enrollment Period

5.5 years

First QC Date

July 12, 2023

Last Update Submit

April 23, 2024

Conditions

Keywords

obesitypublic healthtelemedicine

Outcome Measures

Primary Outcomes (1)

  • Rates of patients lost to follow up

    Rates of patients lost to follow up measured in both arms and compared 4 years after randomization

    4 years

Secondary Outcomes (3)

  • The evolution of quality of life, self-esteem and perceived health compared to baseline

    1,2,3 and 4 years

  • Rate of patients lost to follow-up will be assessed at standard annual visits at 1, 2 and 3 years after randomization

    1,2 and 3 years

  • Change in waist circumference (cm) compared with the baseline measurement will be assessed at standard annual visits at 1, 2, 3 and 4 years after randomization.

    1,2,3 and 4 years

Study Arms (2)

Standard multidisciplinary follow-up reinforced with telemedicine

EXPERIMENTAL

Standard annual multidisciplinary follow-up, reinforced with telemedicine (remote quarterly motivational interviews)

Other: Quarterly remote motivational interviews

Standard multidisciplinary follow up

NO INTERVENTION

Standard annual multidisciplinary follow-up without telemedicine follow up

Interventions

Remote motivational interview will be in the form of quarterly telephone call (at 3, 6 and 9 months after the start of annual follow up; the patient is seen again at 12 months as part of the annual follow-up) and this for 4 years. It will be performed by medical staff trained in motivational interviewing and who have completed at least 40 hours training in therapeutic education

Standard multidisciplinary follow-up reinforced with telemedicine

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Woman or Male aged from 18 to 60 years old included
  • Patient in obesity (BMI\> or = 30)
  • Patient who has completed a multidisciplinary medical program for obesity management, as a first- or second-line intention (after initial obesity management) at the investigating center
  • Affiliation to a social security scheme
  • Patient informed of the study and who had signed the informed consent form
  • Management of obesity within the framework of an exclusively interventional program, without redirection to a medical program
  • Managing obesity as part of a post-operative program
  • Pregnant or breastfeeding women
  • Patients deprived of liberty
  • Patients under legal protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Saint-François

Châteauroux, 36000, France

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Françoise LEVITTA, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study concerns patients who ended the 6 months obesity treatment program proposed by the center. At the end of this 6 months care phase, patients will be randomized in 2 groups (ratio 1:1). The intervention will be and addition of telemedicine quarterly follow up (remote motivational interviews) to the standard multidisciplinary follow-up post care management program
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2023

First Posted

July 20, 2023

Study Start

September 1, 2024

Primary Completion (Estimated)

March 1, 2030

Study Completion (Estimated)

March 1, 2030

Last Updated

April 24, 2024

Record last verified: 2024-04

Locations